Manager × security

Parallel Advisors, LLC CORT holdings history

Who else holds this security? →

CORCEPT THERAPEUTICS INC · CUSIP 218352102 · CIK 1690010

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Parallel Advisors, LLC reported 3.96M CORT (shares), valued at $344.51M, or 5.26% of its reported non-derivative portfolio. Filed 2026-08-05.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
5.26%
Shares
3.96M
3,962,177
Reported value
$344.51M
USD

Shares decreased 0.38%; reported value increased 114.88%, and weight changed +2.37 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20265.26%3,962,177SEC filing ↗Filed Aug 5, 2026
Q1 20262.89%3,977,404SEC filing ↗Filed Jun 3, 2026Amended
Q4 20252.47%3,879,141SEC filing ↗Filed Feb 11, 2026
Q3 20255.90%3,871,452SEC filing ↗Filed Nov 13, 2025
Q2 20255.68%3,871,123SEC filing ↗Filed Jul 8, 2025
Q1 20254.97%3,972,416SEC filing ↗Filed Apr 8, 2025
Q4 20244.36%3,829,632SEC filing ↗Filed Feb 10, 2025
Q3 20244.17%3,813,724SEC filing ↗Filed Nov 13, 2024
Q2 20243.18%3,815,760SEC filing ↗Filed Aug 8, 2024
Q1 20242.60%3,815,677SEC filing ↗Filed May 6, 2024
Q4 20233.63%3,768,245SEC filing ↗Filed Feb 12, 2024
Q3 20233.38%3,723,483SEC filing ↗Filed Nov 14, 2023Amended

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20233.38%3,723,483$101.45MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Nov 14, 2023
Q4 20233.63%3,768,245$122.39MShares increased 1.20%; reported value increased 20.65%, and weight changed +0.25 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 12, 2024
Q1 20242.60%3,815,677$96.12MShares increased 1.26%; reported value decreased 21.47%, and weight changed -1.03 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 6, 2024
Q2 20243.18%3,815,760$123.97MShares increased 0.00%; reported value increased 28.98%, and weight changed +0.58 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 8, 2024
Q3 20244.17%3,813,724$176.50MShares decreased 0.05%; reported value increased 42.37%, and weight changed +0.99 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2024
Q4 20244.36%3,829,632$192.98MShares increased 0.42%; reported value increased 9.33%, and weight changed +0.19 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 10, 2025
Q1 20254.97%3,972,416$219.65MShares increased 3.73%; reported value increased 13.82%, and weight changed +0.61 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 8, 2025
Q2 20255.68%3,871,123$284.14MShares decreased 2.55%; reported value increased 29.36%, and weight changed +0.71 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 8, 2025
Q3 20255.90%3,871,452$321.76MShares increased 0.01%; reported value increased 13.24%, and weight changed +0.22 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2025
Q4 20252.47%3,879,141$134.99MShares increased 0.20%; reported value decreased 58.04%, and weight changed -3.43 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 11, 2026
Q1 20262.89%3,977,404$160.33MShares increased 2.53%; reported value increased 18.77%, and weight changed +0.42 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jun 3, 2026
Q2 20265.26%3,962,177$344.51MShares decreased 0.38%; reported value increased 114.88%, and weight changed +2.37 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 5, 2026
Parallel Advisors, LLC · CORCEPT THERAPEUTICS INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1690010","quarter":"2026Q2","cusip":"218352102"}

get_institutional_manager_history
{"cik":"1690010","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.